Skip to main content
SpringerLink
Log in

Measles Vaccination and Inflammatory Bowel Disease

Controversy Laid to Rest?

  • Current Opinion
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

The increasing incidence of Crohn’s disease has lead to speculation about changes in exposures to environmental or infectious agents. Considerable attention has focused on the role of measles infection and/or vaccination in the pathogenesis of Crohn’s disease and ulcerative colitis.

Current evidence regarding the association between measles vaccination and inflammatory bowel disease (IBD) comprises analytic epidemiological studies, a case-series report and ecological studies. The first of these, a 1995 cohort study, found an association between measles vaccination and Crohn’s disease and ulcerative colitis, but was widely questioned on methodological grounds. This was followed by a 1997 case-control study showing no association between measles vaccination and IBD. In 1998, public concern was rekindled by a report of 12 children with nonspecific colitis, ileal-lymphoid-nodular hyperplasia, and developmental disorders largely attributed to measles-mumps-rubella vaccine, but the nature of the report limited its scientific conclusions. Two additional studies, one case-control and one cohort, then followed and neither found an association with measles vaccination. Of the several ecological studies of measles vaccine coverage or measles schedule changes, none found an association with rates of IBD.

The role of measles infection in IBD has been examined more extensively with studies of in utero measles exposure, measles infection early in life, and laboratory based investigations. An initial report of high rates of Crohn’s disease among pregnancies affected by measles infection was followed by negative studies. Numerous case-control and ecological studies of children with measles infections early in life have also had discordant findings. Of three recent cohort studies, two showed no relationship between infection with early measles exposure and risk for IBD, while one found an approximate 3-fold elevation in risk. Laboratory investigations into persistent measles infection and IBD have been contentious. While some investigators have claimed to find persistent measles infection among patients with IBD, others, using highly sensitive polymerase chain reaction techniques, have not been able to replicate the findings. Recent controversy has centred on whether there is any evidence for molecular mimicry in the pathogenesis of IBD.

In summary, available evidence does not support an association between measles-containing vaccines and risk of IBD, nor between measles infection and IBD. While further research is necessary into the causal factors underlying Crohn’s disease and ulcerative colitis, continued public education efforts are needed to reassure the public about vaccine safety and to prevent declines in vaccine coverage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gollop JH, Phillips SF, Melton LJ, et al. Epidemiologic aspects of Crohn’s disease: a population based study in Olmstead County, Minnesota, 1943–1982. Gut 1988; 29: 49–56

    Article  PubMed  CAS  Google Scholar 

  2. Barton, JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983: marginal fall in ulcerative colitis, three-fold rise in Crohn’s disease. Gut 1989; 20: 618–22

    Article  Google Scholar 

  3. Calkins BM, Whittaker DJ, Rider AA, et al. Trends in incidence rates of ulcerative colitis and Crohn’s disease. Dig Dis Sci 1984; 29: 10: 913–20

    Article  PubMed  CAS  Google Scholar 

  4. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there any difference between north and south? Results of the European Study on Inflammatory Bowel Disease. Gut 1996; 39: 690–7

    Article  PubMed  CAS  Google Scholar 

  5. Loftus Jr EV, Silverstein MD, Sandborn WJ, et al. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161–8

    Article  PubMed  Google Scholar 

  6. Ekbom A, Adami HO, Helmick CG, et al. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990; 132: 1111–10

    PubMed  CAS  Google Scholar 

  7. Ekbom A, Wakefield AJ, Zack M, et al. Perinatal measles infection and subsequent Crohn’s disease. Lancet 1994; 344: 508–10

    Article  PubMed  CAS  Google Scholar 

  8. Thompson NP, Montgomery SM, Pounder RE, et al. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345: 1071–74

    Article  PubMed  CAS  Google Scholar 

  9. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoidnodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637–41

    Article  PubMed  CAS  Google Scholar 

  10. Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn’s disease. J Med Virol 1993; 39: 345–53

    Article  PubMed  CAS  Google Scholar 

  11. MMR vaccine coverage falls after adverse publicity. Commun Dis Rep CDR Wkly 1998; 8: 43–44

    Google Scholar 

  12. Begg N, Ramsey M, White J, et al. Media dents confidence in MMT vaccine. BMJ 1998; 316: 561

    Article  Google Scholar 

  13. Thomas D Rh, Salmon RL, King J. Rates of first measles-mumps-rubella immunization in Wales (UK) [letter]. Lancet 1998; 351: 1927

    Article  PubMed  CAS  Google Scholar 

  14. Davis RL, Kramarz P, Bohlke K, et al. MMR and other measles-containing vaccines do not increase risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink Project. Arch Pediatr Adolesc Med 2001; 155: 354–9

    PubMed  CAS  Google Scholar 

  15. Montgomery SM, Morris DL, Pounder RE, et al. Paramyxo-virus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999; 116: 796–803

    Article  PubMed  CAS  Google Scholar 

  16. Patriarca PA, Beeler JA. Measles vaccination and inflammatory bowel disease. Lancet 1995; 345: 1062–3

    Article  PubMed  CAS  Google Scholar 

  17. Farrington P, Miller E. Measles vaccination as a risk factor for inflammatory bowel disease [letter]. Lancet 1995; 345: 1362

    Article  PubMed  CAS  Google Scholar 

  18. Feeney M, Ciegg A, Winwood P, et al. A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet 1997; 350: 764–6

    Article  PubMed  CAS  Google Scholar 

  19. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998; 351: 611–2

    Article  PubMed  CAS  Google Scholar 

  20. Lee JW, Melgaard B, Clements CJ, et al. Autism, inflammatory bowel disease, and MMR vaccine [letter]. Lancet 1998; 351: 905

    Article  PubMed  CAS  Google Scholar 

  21. Payne C, Mason B. Autism, inflammatory bowel disease, and MMR vaccine [letter]. Lancet 1998; 351: 907

    Article  PubMed  CAS  Google Scholar 

  22. Lindley KJ, Milla PJ. Autism, inflammatory bowel disease, and MMR vaccine [letter]. Lancet 1998; 351: 907

    Article  PubMed  CAS  Google Scholar 

  23. Morris DL, Montgomery SM, Thompson NP, et al. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 2000; 95: 3507–12

    Article  PubMed  CAS  Google Scholar 

  24. Hermon-Taylor J, Ford J, Sumar N, et al. Measles virus and Crohn’s disease. Lancet 1995; 345: 922–3

    Article  PubMed  CAS  Google Scholar 

  25. Miller E, Waight P. Measles, measles vaccination, and Crohn’s disease: second immunisation has not affected incidence in England [letter]. BMJ 1998; 316: 1745

    Article  PubMed  CAS  Google Scholar 

  26. Pebody RG, Paunio M, Ruutu P. Measles, measles vaccination and Crohn’s disease: Crohn’s disease has not increased in Finland. BMJ 1998; 316: 1745–6

    Article  PubMed  CAS  Google Scholar 

  27. Markowitz LE, Katz SL. Measles Vaccine. In: Plotkin SA, Mortimer EA, editors. Vaccines. 2nd ed. Philadelphia: WR Saunders, 1994: 229–76

    Google Scholar 

  28. Ekbom A, Daszak P, Kraaz W, et al. Crohn’s disease after inutero measles virus exposure. Lancet 1996; 348: 515–7

    Article  PubMed  CAS  Google Scholar 

  29. Nielsen LLW, Nielsen NM, Melbye M, et al. Exposure to measles in utero and Crohn’s disease: Danish register study. BMJ 1998; 316: 196–7

    Article  PubMed  CAS  Google Scholar 

  30. Jones P, Fine P, Piracha S. Crohn’s disease and measles. Lancet 1997; 349: 473–4

    Article  PubMed  CAS  Google Scholar 

  31. Wurzelman JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994; 39: 555–60

    Article  Google Scholar 

  32. Haslam N, Mayberry JF, Hawthorne AB, et al. Measles, month of birth, and Crohn’s disease. Gut 2000; 47: 801–3

    Article  PubMed  CAS  Google Scholar 

  33. Pardi DS, Tremaine WJ, Sandborn WJ, et al. Early measles virus infection is associated with the development of inflammatory bowel disease. Am J Gastroenterol 2000 Jun; 95: 1480–5

    Article  PubMed  CAS  Google Scholar 

  34. Thompson NP, Montgomery SM, Wadsworth MEJ, et al. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000; 12: 25–30

    Article  PubMed  CAS  Google Scholar 

  35. Anderson P. Another media scare about MMR vaccine hits Britain. BMJ 1999; 318: 1578

    Article  PubMed  CAS  Google Scholar 

  36. Lewin J, Dhillon AP, Sim R, et al. Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut 1995; 36: 5654–9

    Article  Google Scholar 

  37. Daszak P, Purcell M, Lewin J, et al. Detection and comparative analysis of persistent measles virus infection in Crohn’s disease by immunogold electron microscopy. J Clin Pathol 1997; 50: 299–304

    Article  PubMed  CAS  Google Scholar 

  38. Miyamoto H, Tanaka T, Kitamoto N, et al. Detection of immuno-reactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn’s disease. J Gastroenterol 1995; 30: 28–33

    Article  PubMed  CAS  Google Scholar 

  39. Kawashima H, Mori T, Kashiwagi Y, et al. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 45; 2000: 723–9

    Article  PubMed  CAS  Google Scholar 

  40. Iizuka M, Nakagomi O, Chiba M, et al. Absence of measles virus in Crohns disease [letter]. Lancet 1995; 345: 199

    PubMed  CAS  Google Scholar 

  41. Haga Y, Funakoshi O, Kuroe K, et al. Absence of measles viral genomic sequence in intestinal tissues from Crohn’s disease by nested polymerase chain reaction. Gut 1996; 38: 211–5

    Article  PubMed  CAS  Google Scholar 

  42. Afzal MA, Armitage E, Begley J, et al. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes. J Med Virol 1998; 55: 243–9

    Article  PubMed  CAS  Google Scholar 

  43. Chadwick N, Bruce IJ, Schepelmann S, et al. Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. J Med Virol 1998; 55: 305–11

    Article  PubMed  CAS  Google Scholar 

  44. Iizuka M, Masamune O. Measles vaccination and inflammatory bowel disease [letter]. Lancet 1997: 350: 1775

    Article  PubMed  CAS  Google Scholar 

  45. Iizuka M, Chiba M, Yukawa M, et al. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease. Gut 2000; 46: 163–9

    Article  PubMed  CAS  Google Scholar 

  46. Wakefield AJ, Montgomery SM. Immunohistochemical analysis of measles related antigen in IBD [letter]. Gut 2001; 48: 136

    Article  PubMed  CAS  Google Scholar 

  47. Iizuka M, Itou H, Chiba M, et al. The MMR question [letter]. Lancet; 2000: 356: 160

    Article  PubMed  CAS  Google Scholar 

  48. Measles: United States, 1999. MMWR Morb Mortal Wkly Rep 2000 Jun 30; 49 (25): 557–60

  49. Measles, MMR and autism: the confusion continues. Lancet 2000; 355: 1379

  50. Gellin BG, Schaffner W. The risk of vaccination: the importance of negative studies. N Engl J Med 2001; 344: 372–3

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by Contract 200-95-0957 from the Centers for Disease Control and Prevention’s Comprehensive Linked Data Collection of Medical Events and Immunization.

Author information

Authors and Affiliations

  1. Departments of Paediatrics & Epidemiology, Child Health Institute, University of Washington Schools of Medicine and Public Health, Box 358853, 146 North Canal Street, Suite 300, Seattle, WA 98103, USA

    Robert L. Davis

  2. Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA

    Robert L. Davis & Kari Bohlke

Authors
  1. Robert L. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kari Bohlke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert L. Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, R.L., Bohlke, K. Measles Vaccination and Inflammatory Bowel Disease. Drug-Safety 24, 939–946 (2001). https://doi.org/10.2165/00002018-200124130-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200124130-00001

Keywords

Search

Navigation